Capstone Investment Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Capstone Investment Advisors, LLC

  • $30.4 Billion
  • Q3 2024

A detailed history of Capstone Investment Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 958 shares of REGN stock, worth $713,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares
958
Previous 4,900 80.45%
Holding current value
$713,326
Previous $5.15 Million 80.45%
% of portfolio
0.0%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $319,516 - $374,949
-312 Reduced 24.57%
958 $1.01 Million
Q2 2024

Aug 14, 2024
SELL
$883.2 - $1071.19 $205,785 - $249,587
-233 Reduced 15.5%
1,270 $1.33 Million
Q1 2024

May 01, 2024
BUY
$902.69 - $993.35 $951,435 - $1.05 Million
1,054 Added 234.74%
1,503 $1.45 Million
Q4 2023

Feb 12, 2024
BUY
$775.18 - $881.7 $348,055 - $395,883
449 New
449 $394,000
Q2 2023

Aug 10, 2023
BUY
$700.03 - $830.35 $395,516 - $469,147
565 New
565 $405,000
Q4 2022

Feb 10, 2023
BUY
$705.89 - $766.39 $4,235 - $4,598
6 Added 12.5%
54 $38,000
Q3 2022

Nov 10, 2022
BUY
$573.97 - $724.32 $13,775 - $17,383
24 Added 100.0%
48 $33,000
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $2.2 Million - $2.96 Million
-4,006 Reduced 99.4%
24 $14,000
Q1 2021

May 17, 2021
SELL
$446.73 - $548.2 $9.18 Million - $11.3 Million
-20,555 Reduced 83.61%
4,030 $1.91 Million
Q4 2020

Feb 16, 2021
BUY
$478.3 - $607.98 $7.46 Million - $9.48 Million
15,596 Added 173.5%
24,585 $11.9 Million
Q3 2020

Nov 16, 2020
BUY
$544.75 - $658.21 $4.75 Million - $5.74 Million
8,725 Added 3304.92%
8,989 $5.03 Million
Q2 2020

Aug 14, 2020
SELL
$493.32 - $643.92 $6.99 Million - $9.13 Million
-14,174 Reduced 98.17%
264 $165,000
Q4 2019

Feb 14, 2020
SELL
$274.13 - $376.51 $3.22 Million - $4.42 Million
-11,736 Reduced 44.84%
14,438 $5.42 Million
Q3 2019

Nov 14, 2019
SELL
$273.46 - $318.39 $1.78 Million - $2.07 Million
-6,512 Reduced 19.92%
26,174 $7.26 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $9.08 Million - $12.6 Million
30,305 Added 1272.78%
32,686 $10.2 Million
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $406,683 - $480,450
1,093 Added 84.86%
2,381 $978,000
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $452,268 - $526,160
1,288 New
1,288 $520,000
Q1 2018

May 15, 2018
SELL
$315.82 - $393.78 $346,138 - $431,582
-1,096 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $213,743 - $280,090
596 Added 119.2%
1,096 $412,000
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $215,690 - $252,000
500
500 $223,000

Others Institutions Holding REGN

# of Institutions
1,530
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email